CoVaccine HT™ Adjuvant Potentiates Robust Immune Responses to Recombinant SARS-CoV-2 Spike S1 Immunization

The current COVID-19 pandemic has claimed hundreds of thousands of lives and its causative agent, SARS-CoV-2, has infected millions, globally. The highly contagious nature of this respiratory virus has spurred massive global efforts to develop vaccines at record speeds. In addition to enhanced immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Haun, Brien K., Lai, Chih-Yun, Williams, Caitlin A., Wong, Teri Ann S., Lieberman, Michael M., Pessaint, Laurent, Andersen, Hanne, Lehrer, Axel T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661386/
https://www.ncbi.nlm.nih.gov/pubmed/33193454
http://dx.doi.org/10.3389/fimmu.2020.599587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661386/
https://www.ncbi.nlm.nih.gov/pubmed/33193454
http://dx.doi.org/10.3389/fimmu.2020.599587

Ejemplares similares